4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001209191-22-004877
10% owner sold 134,558 shares at an average $1.50 ($202,209)
From the SEC's structured data for this filing
Trades in this filing
New Enterprise Associates 14, L.P. · 10% owner
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-21 | Sale : show line 1 in the form | −11,622 | $1.67 | $19,389 | 3,428,537 | D |
| 2022-01-24 | Sale : show line 2 in the form | −19,984 | $1.55 | $31,017 | 3,408,553 | D |
| 2022-01-25 | Sale : show line 3 in the form | −102,952 | $1.47 | $151,803 | 3,305,601 | D |
| Open-market sales · 134,558 sh · avg $1.50 · $202,209 | ||||||
Loading xslF345X03/doc4.xml…